ANTIMICROBIAL RESISTANCE
You make a difference in the fight against antimicrobial resistance.
Antimicrobial resistance (AMR) was declared a top 10 global public health threat in 20191, however, recent reports reveal that actions and investments are still needed to prevent a potential AMR public health crisis. AMR occurs when bacteria, fungi, viruses, and parasites mutate naturally over time and no longer respond to modern medicines—a problem exacerbated by the misuse and overuse of antimicrobials.
At bioMérieux we provide the most complete solution to support antimicrobial stewardship (AMS) initiatives. We partner with healthcare systems and professionals like you, contributing expertise and diagnostic innovation that is adaptable and scalable to current and future AMS needs.
Optimize Diagnostics. Optimize Therapy. With our complete solutions for AMS.
“We Are Losing Kids Not From Their Cancer,
But From Infections Antibiotics Cannot Fight.”
Patient Story: Menia Koukougianni
Menia Koukougianni was thrust into the conversation of AMR after her daughter’s cancer treatment was interrupted by a new threat— a healthcare acquired bacterial infection. Here, Menia expresses the need for better education and collaboration to ensure antibiotics are used wisely in patient therapy, thereby remaining lifesaving for future generations.
AMS: The best solution to combat AMR.
AMS is defined as coordinated interventions which seek to limit patient exposure to antibiotics. The goal of AMS initiatives is to ensure that the right antibiotic is given to the right patient at the right time, with the right dose and via the right route— causing the least harm to the patient.
You can do more with Stewardship.
- Detect, prevent, and control multi-drug resistant infections
- Minimize the risk of healthcare-associated infections (HAI)
- Optimize the use of antibiotics
- Monitor and track resistance trends
Reduce Hospital Costs and Improve Patient Outcomes with Antimicrobial Stewardship
Gain insights to optimize care in your healthcare setting with an in-depth analysis from our expert:
Dr. Victor Leung
Medical Director, Infection Prevention and Control and Medical Lead for the Antimicrobial Stewardship Program at Providence Health Care in Vancouver
Diagnostics: The Heart of Antimicrobial Stewardship
Expert Insights: Luke Moore, PHD
Luke Moore, PhD, an infectious disease physician and clinical microbiologist in London, describes how optimized diagnostics and data-driven solutions can benefit antimicrobial stewardship initiatives by:
- Improving speed to diagnosis in a cost-effective manner
- Informing infection prevention measures
- Monitoring and analyzing resistance patterns throughout institutions
- Supporting clinical decision making at both the patient and population level
A Complete Solution for the AMS Patient Pathway
bioMérieux provides the most complete solution to support AMS initiatives with 80% of our product portfolio dedicated to the fight against AMR. We help healthcare systems maximize diagnostics and data to detect, target, and treat drug-resistant infections— with integrated solutions that support the right antibiotics for the right person and only when necessary.
Product availability varies by country. Please consult your local bioMérieux representative.
Explore bioMérieux’s Complete Solution For AMS
Take Me ThereAdditional Resources
EDUCATION bioMérieux Medical Education Resource Hub
Free-access to medical edcucation webinars, tutorials, and other resources.
EDUCATION bioMérieux Learning Lounge
Explore on-demand education, timely thought leadership, and diagnostic solutions supporting the fight against AMR.
BLOG bioMérieux Living Diagnostics Blog
Listen to clinical insights and interviews with microbiology experts about the value of diagnostics.
References
- WHO. Antimicrobial resistance. Who.int. Published October 13, 2020. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance